Prime

Type your tag names separated by a space and hit enter

Comparison of Four Serological Methods and Two Reverse Transcription-PCR Assays for Diagnosis and Surveillance of Zika Virus Infection.

Abstract

Zika virus (ZIKV) is a mosquito-borne flavivirus that is responsible for recent explosive epidemics in the Americas. Notably, ZIKV infection during pregnancy has been found to cause congenital birth defects, including microcephaly, and ZIKV has been associated with Guillain-Barré syndrome in adults. Diagnosis and surveillance of Zika in the Americas have been challenging due to similar clinical manifestations and extensive antibody cross-reactivity with endemic flaviviral diseases, such as dengue. We evaluated four serological and two reverse transcription-PCR (RT-PCR) methods in acute-phase (mean day, 1.8), early-convalescent-phase (mean day, 16.7), and late-convalescent-phase (mean, ~7 months) samples from the same individuals in a long-term pediatric cohort study in Nicaragua. Well-characterized samples from 301 cases of Zika, dengue, or non-Zika, nondengue febrile illnesses were tested. Compared to a composite reference, an in-house IgM antibody capture enzyme-linked immunosorbent assay (MAC-ELISA) and the NIAID-Biodefense and Emerging Infections (BEI) MAC-ELISA measuring IgM yielded sensitivities of 94.5% and 70.1% and specificities of 85.6% and 82.8%, respectively. The NS1 blockade-of-binding ELISA measuring anti-ZIKV NS1 antibody levels yielded sensitivities of 85.0% and 96.5% and specificities of 91.4% and 92.6% at early and late convalescence, respectively. An inhibition ELISA detecting total anti-ZIKV antibodies had sensitivity and specificity values of 68.3% and 58.3% for diagnosis and 94.0% and 98.6% for measuring annual infection incidence. Finally, the ZCD and Trioplex real-time RT-PCR assays detecting Zika, chikungunya, and dengue viruses both yielded a sensitivity of 96.1% and specificity of 100%. Together, these assays resolve the urgent need for diagnostic and surveillance tools for countries affected by Zika virus infections.

Links

  • Publisher Full Text
  • Authors+Show Affiliations

    ,

    Laboratorio Nacional de Virología, Centro Nacional de Diagnóstico y Referencia, Ministry of Health, Managua, Nicaragua. Sustainable Sciences Institute, Managua, Nicaragua.

    ,

    Sustainable Sciences Institute, Managua, Nicaragua.

    ,

    Sustainable Sciences Institute, Managua, Nicaragua.

    ,

    Laboratorio Nacional de Virología, Centro Nacional de Diagnóstico y Referencia, Ministry of Health, Managua, Nicaragua. Sustainable Sciences Institute, Managua, Nicaragua.

    ,

    Laboratorio Nacional de Virología, Centro Nacional de Diagnóstico y Referencia, Ministry of Health, Managua, Nicaragua. Sustainable Sciences Institute, Managua, Nicaragua.

    ,

    Sustainable Sciences Institute, Managua, Nicaragua.

    ,

    Laboratorio Nacional de Virología, Centro Nacional de Diagnóstico y Referencia, Ministry of Health, Managua, Nicaragua. Sustainable Sciences Institute, Managua, Nicaragua.

    ,

    Laboratorio Nacional de Virología, Centro Nacional de Diagnóstico y Referencia, Ministry of Health, Managua, Nicaragua. Sustainable Sciences Institute, Managua, Nicaragua.

    ,

    Laboratorio Nacional de Virología, Centro Nacional de Diagnóstico y Referencia, Ministry of Health, Managua, Nicaragua. Sustainable Sciences Institute, Managua, Nicaragua.

    ,

    Laboratorio Nacional de Virología, Centro Nacional de Diagnóstico y Referencia, Ministry of Health, Managua, Nicaragua. Sustainable Sciences Institute, Managua, Nicaragua.

    ,

    Humabs Biomed SA, subsidiary of Vir Biotechnology, Inc., Bellinzona, Switzerland.

    ,

    Department of Medicine, Division of Infectious Diseases, Emory University, Atlanta, Georgia, USA.

    ,

    Sustainable Sciences Institute, Managua, Nicaragua. Health Center Sócrates Flores Vivas, Ministry of Health, Managua, Nicaragua.

    ,

    Sustainable Sciences Institute, Managua, Nicaragua. Division of Infectious Diseases and Vaccinology, School of Public Health, University of California, Berkeley, Berkeley, California, USA.

    Sustainable Sciences Institute, Managua, Nicaragua eharris@berkeley.edu. Division of Infectious Diseases and Vaccinology, School of Public Health, University of California, Berkeley, Berkeley, California, USA.

    Source

    Pub Type(s)

    Journal Article

    Language

    eng

    PubMed ID

    29305550